Lori Davis
Psychiatry · Tuscaloosa, ALNPI 1740250042
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $117,972 of the $160,953 with a category attached, or 73.3%. 11 manufacturers reported payments, led by Otsuka Pharmaceutical Development & Commercialization, Inc. at 59.1% of the total. 2025 is the largest year on record at $56,968, 2.7 times the $20,848 reported in 2019. Among psychiatry clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 130 payments — averaging $1238.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka Pharmaceutical Development & Commercialization, Inc.$95K
- Boehringer Ingelheim International GmbH$27K
- Boehringer Ingelheim$17K
- Janssen Research & Development, LLC$12K
- Otsuka America Pharmaceutical, Inc.$6K
- H. Lundbeck A S$4K
- plus $453 from 5 others
Across 12 payments — averaging $29,520 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Alkermes, Inc.$354K
What the payments were for
- Consulting fees$117,97273%
- Speaking & faculty fees$21,07413%
- Travel & lodging$19,46612%
- Food & beverage$2,4412%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 73 | $95,045 |
| Boehringer Ingelheim International GmbH | 13 | $27,331 |
| Boehringer Ingelheim | 9 | $16,736 |
| Janssen Research & Development, LLC | 11 | $11,931 |
| Otsuka America Pharmaceutical, Inc. | 14 | $5,591 |
| H. Lundbeck A S | 4 | $3,867 |
| Lundbeck LLC | 1 | $134 |
| Sunovion Pharmaceuticals Inc. | 1 | $115 |
| Novo Nordisk | 1 | $89 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $62 |
| AbbVie | 2 | $52 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$160,953 in reported general payments places this provider in the 95th percentile of 400 psychiatry providers in Alabama.
Other psychiatry in Tuscaloosa
- John HubbardTuscaloosa$15K
- Aftab KhanTuscaloosa$10K
- Armand SchachterBirmingham$758K
- Stephen HughesBirmingham$683K
- Leesha Ellis CoxBirmingham$653K
- Godehard OepenBirmingham$516K
- Scariya KumaramangalamHuntsville$440K
- Mark HaygoodMobile$348K
- Bradley SadlerMobile$124K
- Brandi Rudolph BollingJasper$97K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.